Fulminant hepatitis
Springer Seminars in Immunopathology · 1990
DOI: 10.1007/bf00192680 ↗At a glance
Übersichtsarbeit in Springer Seminars in Immunopathology, 1990. Written by S Sinclair and 2 co-authors. Institution: University of Toronto, Canada. Cited 4 times so far (Crossref); 104 references. The full text is freely available in PubMed Central. Funded by: Wellcome Trust.
Abstract (original language)
ConclusionIn conclusion, evidence exists that cellular and humoral immune-mediated processes result in hepatic necrosis in FH. Activation of the immune coagulation system appears to be an integral part of the inflammatory process resulting in fibrin thrombi which have been demonstrated in the liver, kidneys and lungs of patients with FH. A beneficial role of PG in the treatment of FH has been demonstrated, but controlled trials are required to firmly establish the efficacy of these agents. At present liver transplantation remains the treatment of choice in selected patients with FH. Further studies of the role of the immune system in the pathogenesis of this disease are required to devise more effective therapeutic strategies.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- University of Toronto, Canada.
Funding
- Wellcome Trust
Cite
APA
Sinclair, S., Wakefield, A., & Levy, G. (1990). Fulminant hepatitis. Springer Seminars in Immunopathology. https://doi.org/10.1007/bf00192680
Vancouver
Sinclair S, Wakefield A, Levy G. Fulminant hepatitis. Springer Seminars in Immunopathology. 1990. doi:10.1007/bf00192680
BibTeX
@article{Sinclair1990,
author = {Sinclair, S and Wakefield, A and Levy, G},
title = {Fulminant hepatitis},
journal = {Springer Seminars in Immunopathology},
year = {1990},
doi = {10.1007/bf00192680}
}
EUVIMED